X
20
Cipla Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is AMLODIPINE MESYLATE MONOHYDRATE, with a corresponding US DMF Number 17107.
Remarkably, this DMF maintains an Inactive status since its submission on January 21, 2004, highlighting commitment to regulatory compliance.